3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Rhabdomyosarcoma
3
Hodgkin Disease
3
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
HR+HER2- Breast Cancer
1
Desmoplastic Small Round Cell Tumor
1
Adenocarcinoma
1
Interventions
Injections
8
pembrolizumab
4
Pemetrexed
4
Carboplatin
4
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
trifluridine tipiracil drug combination
2
sotorasib
2
fludarabine
2
Paclitaxel
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
zimberelimab
1
trametinib
1
toripalimab
1
tislelizumab
1
sacituzumab govitecan
1
palbociclib
1
netrin-1 inhibitor NP137
1
cemiplimab
1
WW Domain-Containing Oxidoreductase
1
SYS6006 COVID-19 vaccine
1
Panitumumab
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
Fulvestrant
1
Etoposide
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
Vinorelbine
×
90 days
×
Clear all
No trials found.